This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Grant Agreement No. 956851.

Author Archives: rabab

Alessia Favaron successfully defending her PhD on how JAK inhibitor drugs for inflammatory bowel disease (IBD) interact with the human gut microbiome

A significant academic milestone was achieved on the 6th of November, 2024 as Alessia, a COLOTAN doctoral candidate at University College London , successfully defended her PhD thesis titled “Interactions between medicines and the human gut microbiome”. The defense marked the culmination of years of hard work and research in the field of gut microbiota. Here’s Alessia on her proud ...

Read More »

Outstanding cum laude! 1st COLOTAN PhD defence by Ines Pârente

On July 22nd, Ines Parente (ESR13 of the EU H2020 MSCA ITN COLOTAN) performed the defence of her doctoral thesis entitled “Colonoids and cytokines: an in vitro model of drug absorption in the inflamed gut”: she presented her project to prof. Barocelli, prof. Fornai and prof. Colucci, members of the committtee, who had the possibility to appreciate her progresses during the ...

Read More »

A new COLOTAN publication that explores the potential of human intestinal organoids

Exploring the potential of human intestinal organoids: Applications, challenges, and future direction Inês A. Parente, Linda Chiara, Simona Bertoni Published in Life Sciences Abstract The complex and dynamic environment of the gastrointestinal tract shapes one of the fastest renewing tissues in the human body, the intestinal epithelium. Considering the lack of human preclinical studies, reliable models that mimic the intestinal ...

Read More »

A new COLOTAN published article for the better understanding of the luminal conditions in the proximal colon

Characterization of luminal contents from the fasted human proximal colon S. Steigert, J. Brouwers, K. Verbeke, T. Vanuytsel, P. Augustijns In the EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES Abstract To treat colonic diseases more effectively, improved therapies are urgently needed. In this respect, delivering drugs locally to the colon is a key strategy to achieve higher local drug concentrations while minimizing ...

Read More »

Alessia won 2nd place in the “Explore your Entrepreneurial Idea” program!

What an incredible experience it was for Alessia Favaron (COLOTAN ESR9) to develop her business idea in “Explore your Entrepreneurial Idea” program at UCL! She won 2nd place with her HerBioma venture, dedicated to balancing women’s hormonal health with microbiome science. Congratulations to Nidhi Seegobin who was a finalist in the program, and Ieva Karvelyte who won 3rd place!  

Read More »

COLOTAN published an article on the development of a canine artificial colonic mucus model for drug diffusion studies

Development of a canine artificial colonic mucus model for drug diffusion studies V. Barmpatsalou, M. Tjakra, L. Li, I.R. Dubbelboer, E. Karlsson, B. Pedersen Lomstein, C.A.S. Bergström Abstract Colonic mucus is a key factor in the colonic environment because it may affect drug absorption. Due to the similarity of human and canine gastrointestinal physiology, dogs are an established preclinical species ...

Read More »

A review on solidification and oral delivery of biologics to the colon

Solidification and oral delivery of biologics to the colon – A review by COLOTAN researcher Katharina Kopp with the supervision of Lien Saerens (Eurofins), Jody Voorspoels (Eurofins) and Guy Van den Mooter (KU Leuven) that has been published recently in the European Journal of Pharmaceutical Sciences. Abstract The oral delivery of biologics such as therapeutic proteins, peptides and oligonucleotides for ...

Read More »